|4Apr 3, 7:30 PM ET

Auster Martin 4

4 · Ventyx Biosciences, Inc. · Filed Apr 3, 2024

Insider Transaction Report

Form 4
Period: 2024-04-02
Auster Martin
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-04-02$5.40/sh1,405$7,59224,303 total
Footnotes (2)
  • [F1]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Represents the weighted average share price of an aggregate total of 1,405 shares sold in the price range of $5.28 to $5.4062. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    form4-04032024_110436.xmlPrimary